Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 642 (LINC00642) is a member of the long non-coding RNA (lncRNA) family, more specifically classified as a long intergenic non-coding RNA (lincRNA)[1][3][7]. LincRNAs such as LINC00642 are typically over 200 nucleotides in length and located in genomic regions that do not overlap with protein-coding genes, distinguishing them from other classes of lncRNAs[3][7][5]. LINC00642 is transcribed as an RNA molecule but does not encode a protein[1][3]. While many lincRNAs are implicated in a variety of regulatory roles—including chromatin remodeling, epigenetic regulation, and the fine-tuning of gene expression—there is currently very limited functional or disease association information available for LINC00642 specifically[1][3][7]. No evidence presently supports LINC00642 as a direct therapeutic target, disease gene, or actionable biomarker. It is cataloged in genomic databases as an uncharacterized lincRNA and its precise biological functions and clinical relevance remain to be elucidated[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 642 (LINC00642).